| ²é¿´: 1979 | »Ø¸´: 8 | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
³ÕÃÎäìÏæÄ¾³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
ΪʲôÃÀ¹úµÄҩƷ˵Ã÷ÊéµÚ9ÏîÓëµÚ15Ïî×ÜÊÇ¿Õȱ ÒÑÓÐ7È˲ÎÓë
|
||||
|
ÈçÌ⣬ÎÒ¿´¹ýµÄÃÀ¹úҩƷ˵Ã÷Ê飨Label£©¶¼ÊÇÕâÑù£¬ÓÐÊ²Ã´ÃØÃÜÂ𣿠ÃÀ¹úҩƷ˵Ã÷ÊéµÄÄÚÈÝÈçÏ£º Boxed WarningºÚ¿ò¾¯¸æ£¨²¿·ÖÒ©ÎïÑÏÖØ¸±×÷Óã© 1. Indications and UsageÊÊÓ¦Ö¢ÓëÓÃ; 2. Dosage and AdministrationÓÃÁ¿ÓëÓ÷¨ Recommended DoseÍÆ¼öÓÃÁ¿£»Dosage Adjustments/Dose ModificationÓÃÁ¿µ÷Õû 3. Dosage Forms and Strengths¼ÁÐÍÓë¹æ¸ñ 4. Contraindications½û¼ÉÖ¤ 5. Warnings and Precautions×¢ÒâÊÂÏî 6. Adverse Reactions²»Á¼·´Ó¦£¨º¬Í³¼ÆÊý¾Ý£© 7. Drug InteractionsÒ©ÎïÏ໥×÷Óà 8. Use in Specific PopulationsÌØÊâÈËȺÓÃÒ© PregnancyÈÑÉLabor and delivery·ÖÃ䣻Nursing Mothers²¸ÈéÆÚ¸¾Å®£»Pediatric UseС¶ùÓÃÒ©£»Geriatric UseÀÏÈËÓÃÒ©£»Hepatic Impairment¸Î¹¦Äܲ»È«£»Renal ImpairmentÉö¹¦Äܲ»È« 9. Drug Abuse and DependenceÒ©ÎïÀÄÓúÍÒÀÀµÐÔ£¨²¿·ÖÒ©Æ·ÎÞ£© Controlled Substance¹ÜÖÆÒ©Î 10. OverdosageÓÃÒ©¹ýÁ¿ 11. DescriptionÐÔ×´£¨º¬»¯Ñ§Ãû³Æ£¬·Ö×Óʽ£¬·Ö×ÓÁ¿£¬½á¹¹Ê½£¬Àí»¯ÐÔÖÊ£© 12. Clinical PharmacologyÁÙ´²Ò©Àíѧ Mechanism of Action×÷ÓûúÀí£»PharmacodynamicsҩЧ¶¯Á¦Ñ§£»PharmacokineticsÒ©´ú¶¯Á¦Ñ§ 13. Nonclinical Toxicology·ÇÁÙ´²¶¾Àíѧ CarcinogenesisÖ°©£»MutagenesisÖÂÍ»±ä£»Impairment of FertilityÉúÖ³¶¾ÐÔ Animal toxicology and/or pharmacology¶¯Îï¶¾ÀíѧºÍ/»òÒ©Àíѧ 14. Clinical StudiesÁÙ´²Ñо¿ 15. References²Î¿¼£¨²¿·ÖÒ©Æ·ÎÞ£© 16. How Supplied/Storage and Handling°ü×°ÓëÖü²Ø 17. Patient Counseling Information»¼Õß×ÉѯÐÅÏ¢ [ Last edited by ³ÕÃÎäìÏæ on 2013-1-11 at 15:00 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
New Drug Research and Development | Ò©Îï¼ìË÷ |
» ²ÂÄãϲ»¶
SUES&NERCN¿ÎÌâ×é½ÓÊÜ˶ʿÉúµ÷¼Á (ѧ˶1Ãû+ר˶1Ãû)
ÒѾÓÐ0È˻ظ´
SUES&NERCN¿ÎÌâ×é½ÓÊÜ˶ʿÉúµ÷¼Á (ѧ˶1Ãû+ר˶1Ãû)
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ53È˻ظ´
·ÇÈ«ÈÕÖÆ¹«¹²¹ÜÀíÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ҩѧ298·Ö-Ò»Ö¾Ô¸Öйúº£Ñó´óѧ-Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ4È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ0È˻ظ´
¡¾µ÷¼ÁÉϰ¶¡¿985ÁªºÏÅàÑø£¡1007/1055/08/07µÈ£¬²»ÏÞרҵ£¬ÏëÁªÅàµÄËÙÀ´£¡
ÒѾÓÐ3È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ14È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÃÀ¹úҩƷ˵Ã÷Êé²éѯÊý¾Ý¿â£¬Ïë²éѯעÉä¼ÁÅäÖÆºóÎȶ¨ÐÔ¼°ÅäÎé½û¼É£¡£¡
ÒѾÓÐ17È˻ظ´
ÔõÑù´ÓÃÀ¹úFDAÍøÕ¾ÉϲéÕÒ¼°ÏÂÔØÒ©Æ·ËµÃ÷Ê飿
ÒѾÓÐ11È˻ظ´
СÀÇ851226
ľ³æ (ÕýʽдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 167 (¸ßÖÐÉú)
- ½ð±Ò: 2431.2
- ºì»¨: 20
- Ìû×Ó: 789
- ÔÚÏß: 537.3Сʱ
- ³æºÅ: 1437027
- ×¢²á: 2011-10-11
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
9Â¥2013-03-27 16:34:08
hardee
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
´Ë²ÝÓÐÖ÷~
- DRDEPI: 12
- Ó¦Öú: 152 (¸ßÖÐÉú)
- ¹ó±ö: 0.03
- ½ð±Ò: 10929.3
- É¢½ð: 5544
- ºì»¨: 49
- ɳ·¢: 40
- Ìû×Ó: 6865
- ÔÚÏß: 2905.6Сʱ
- ³æºÅ: 891544
- ×¢²á: 2009-11-02
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
³ÕÒÄ×ÓÆ¤: ½ð±Ò+3, Ó¦ÖúÖ¸Êý+1, лл½»Á÷¡£ 2013-01-11 13:43:58
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
³ÕÒÄ×ÓÆ¤: ½ð±Ò+3, Ó¦ÖúÖ¸Êý+1, лл½»Á÷¡£ 2013-01-11 13:43:58
|
¿´µÄÕæ×Ðϸ°¡¡£²éÁËһϣ¬ÃÀ¹úµÄҩƷ˵Ã÷ÊéÖУº µÚ¾ÅÏîΪ£º 9 Drug Abuse and Dependence 9.1 Controlled substance 9.2 Abuse 9.3 Dependence µÚÊ®ÎåÏîΪ£º 15 References ÖÁÓÚΪʲôºÜ¶à¶¼Ê¡ÂÔµô£¬¹À¼ÆÔÚÕâ¸öÎļþÖÐÓÐÌáµ½£¬Äã¿ÉÒÔ¿´¿´£¬ÎÒÊÇÀÁµÃ¿´ÁË£º http://www.accessdata.fda.gov/sc ... earch.cfm?fr=201.56 |

3Â¥2013-01-11 12:48:53
³ÕÃÎäìÏæ
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 3897.3
- É¢½ð: 2200
- ºì»¨: 107
- ɳ·¢: 8
- Ìû×Ó: 2857
- ÔÚÏß: 1192.5Сʱ
- ³æºÅ: 1120792
- ×¢²á: 2010-10-12
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
4Â¥2013-01-11 15:01:06
ľЦЦ
½ð³æ (ÖøÃûдÊÖ)
·Ü¶·
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ¹ó±ö: 1.338
- ½ð±Ò: 1447.1
- É¢½ð: 5828
- ºì»¨: 6
- ɳ·¢: 11
- Ìû×Ó: 2031
- ÔÚÏß: 273.8Сʱ
- ³æºÅ: 695449
- ×¢²á: 2009-02-03
- רҵ: Ò©Îï·ÖÎö

5Â¥2013-01-11 18:03:10













»Ø¸´´ËÂ¥
